Carecube Negative Pressure Isolation Chamber (1BY)
Carecubes, Inc. · Decision date Oct 16, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for the Carecube Negative Pressure Isolation Chamber (1BY), submitted by Carecubes, Inc. of San Francisco, California, under 510(k) number K260180. The device falls under the classification name Chamber, Patient Isolation, regulation number 880.5450, product code LGM, with General Hospital as the regulation medical specialty and review panel. The application was a Traditional 510(k) received on 01/21/2026, with the decision dated 10/16/2026.
SESE in this 510(k) context indicates clearance to market, not premarket approval. The record shows the review was not conducted by a third party, was not a combination product, and had no authorized Predetermined Change Control Plan. The public page does not include the predicate device, the summary of similarities and differences, or any performance data, so the specific basis for the equivalence determination remains unknown from this source.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General Hospital
- Decision date
- Oct 16, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260180
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Carecubes, Inc.
- Product code
- LGM
- Decision code
- SESE
- Decision date
- Oct 16, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Chamber, Patient Isolation.
- Applicant
- Carecubes, Inc.
- Product code
- LGM
- FDA device class
- 2
FDA decision timeline
K260180 received
Application receipt date recorded by FDA.
K260180 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Carecubes, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- San Francisco, CA
Sources and methodology
- Original FDA record: K260180
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records